Published in Environ Health Perspect on May 06, 2013
Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: the NIEHS Nano GO Consortium. Environ Health Perspect (2013) 1.68
Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation. Part Fibre Toxicol (2014) 1.24
A multi-stakeholder perspective on the use of alternative test strategies for nanomaterial safety assessment. ACS Nano (2013) 1.20
Effect of MWCNT size, carboxylation, and purification on in vitro and in vivo toxicity, inflammation and lung pathology. Part Fibre Toxicol (2013) 1.15
Toxicity assessment of zinc oxide nanoparticles using sub-acute and sub-chronic murine inhalation models. Part Fibre Toxicol (2014) 1.10
Genotoxicity of multi-walled carbon nanotubes at occupationally relevant doses. Part Fibre Toxicol (2014) 1.05
Inhalation Exposure to Carbon Nanotubes (CNT) and Carbon Nanofibers (CNF): Methodology and Dosimetry. J Toxicol Environ Health B Crit Rev (2015) 0.98
Aspect ratio plays a role in the hazard potential of CeO2 nanoparticles in mouse lung and zebrafish gastrointestinal tract. ACS Nano (2014) 0.95
Instillation versus inhalation of multiwalled carbon nanotubes: exposure-related health effects, clearance, and the role of particle characteristics. ACS Nano (2014) 0.93
Occupational safety and health criteria for responsible development of nanotechnology. J Nanopart Res (2013) 0.93
Lung injury induced by TiO2 nanoparticles depends on their structural features: size, shape, crystal phases, and surface coating. Int J Mol Sci (2014) 0.93
Biological response to nano-scale titanium dioxide (TiO2): role of particle dose, shape, and retention. J Toxicol Environ Health A (2013) 0.91
Extraction and quantification of carbon nanotubes in biological matrices with application to rat lung tissue. ACS Nano (2013) 0.89
Short versus long silver nanowires: a comparison of in vivo pulmonary effects post instillation. Part Fibre Toxicol (2014) 0.86
PVP formulated fullerene (C60) increases Rho-kinase dependent vascular tissue contractility in pregnant Sprague Dawley rats. Reprod Toxicol (2014) 0.86
Synthesis, characterization, and bioactivity of carboxylic acid-functionalized titanium dioxide nanobelts. Part Fibre Toxicol (2014) 0.81
Pharmaceutical and toxicological properties of engineered nanomaterials for drug delivery. Annu Rev Pharmacol Toxicol (2013) 0.80
IL-33 modulates chronic airway resistance changes induced by multi-walled carbon nanotubes. Inhal Toxicol (2014) 0.78
Immunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulation. Toxicol Mech Methods (2013) 0.78
Nano GO Consortium--a team science approach to assess engineered nanomaterials: reliable assays and methods. Environ Health Perspect (2013) 0.78
Carbon Nanotube and Asbestos Exposures Induce Overlapping but Distinct Profiles of Lung Pathology in Non-Swiss Albino CF-1 Mice. Toxicol Pathol (2016) 0.78
Effect of sonication on particle dispersion, administered dose and metal release of non-functionalized, non-inert metal nanoparticles. J Nanopart Res (2016) 0.77
Comparative lung toxicity of engineered nanomaterials utilizing in vitro, ex vivo and in vivo approaches. J Nanobiotechnology (2014) 0.77
Mitochondrial dysfunction and loss of glutamate uptake in primary astrocytes exposed to titanium dioxide nanoparticles. Nanoscale (2015) 0.77
Atomic layer deposition coating of carbon nanotubes with zinc oxide causes acute phase immune responses in human monocytes in vitro and in mice after pulmonary exposure. Part Fibre Toxicol (2016) 0.77
The pulmonary inflammatory response to multiwalled carbon nanotubes is influenced by gender and glutathione synthesis. Redox Biol (2016) 0.77
Comparative hazard identification by a single dose lung exposure of zinc oxide and silver nanomaterials in mice. PLoS One (2015) 0.77
Facilitating Translational Nanomedicine via Predictive Safety Assessment. Mol Ther (2017) 0.77
Toxicoproteomic analysis of pulmonary carbon nanotube exposure using LC-MS/MS. Toxicology (2015) 0.76
Silver Nanoparticle-Directed Mast Cell Degranulation Is Mediated through Calcium and PI3K Signaling Independent of the High Affinity IgE Receptor. PLoS One (2016) 0.76
Shape-Related Toxicity of Titanium Dioxide Nanofibres. PLoS One (2016) 0.75
Thrombospondin-1 mediates Multi-Walled Carbon Nanotube induced impairment of arteriolar dilation. Nanotoxicology (2016) 0.75
The initial inflammatory response to bioactive implants is characterized by NETosis. PLoS One (2015) 0.75
Contrasting effects of nanoparticle-protein attraction on amyloid aggregation. RSC Adv (2015) 0.75
Pulmonary responses in rat lungs after intratracheal instillation of 4 crystal forms of titanium dioxide nanoparticles. J Occup Health (2016) 0.75
Aerosol generation and characterization of multi-walled carbon nanotubes exposed to cells cultured at the air-liquid interface. Part Fibre Toxicol (2016) 0.75
Heterogeneous Vascular Bed Responses to Pulmonary Titanium Dioxide Nanoparticle Exposure. Front Cardiovasc Med (2017) 0.75
Structure Activity Relationships of Engineered Nanomaterials in inducing NLRP3 Inflammasome Activation and Chronic Lung Fibrosis. NanoImpact (2016) 0.75
Genetic susceptibility to toxicologic lung responses among inbred mouse strains following exposure to carbon nanotubes and profiling of underlying gene networks. Toxicol Appl Pharmacol (2017) 0.75
Toxic potential of materials at the nanolevel. Science (2006) 19.24
Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect (2005) 17.71
Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater (2009) 11.95
Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci (2008) 5.03
Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol (2008) 3.80
The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol (2006) 3.56
Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology (2009) 3.52
Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol Sci (2007) 3.52
Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months. Toxicol Sci (2009) 3.06
Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nanotechnol (2009) 2.78
Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma. Am J Respir Cell Mol Biol (2008) 2.32
Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre Toxicol (2011) 2.08
Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part Fibre Toxicol (2009) 2.06
Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures. Toxicol Sci (2009) 1.99
Potential health impact of nanoparticles. Annu Rev Public Health (2009) 1.80
Absence of carcinogenic response to multiwall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicol Sci (2009) 1.79
Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol (2009) 1.78
Dispersal state of multiwalled carbon nanotubes elicits profibrogenic cellular responses that correlate with fibrogenesis biomarkers and fibrosis in the murine lung. ACS Nano (2011) 1.74
Pulmonary applications and toxicity of engineered nanoparticles. Am J Physiol Lung Cell Mol Physiol (2008) 1.72
Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment--issues and recommendations. Nanotoxicology (2010) 1.71
Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: the NIEHS Nano GO Consortium. Environ Health Perspect (2013) 1.68
Estimates of upper bounds and trends in nano-TiO2 production as a basis for exposure assessment. Environ Sci Technol (2009) 1.48
Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. Nanomedicine (Lond) (2011) 1.28
Nanoparticles as a potential cause of pleural and interstitial lung disease. Proc Am Thorac Soc (2010) 1.22
Nanoparticles in the lung. Nat Biotechnol (2010) 1.14
Translocation of intratracheally instilled multiwall carbon nanotubes to lung-associated lymph nodes in rats. Ind Health (2010) 1.03
Acute pulmonary response of mice to multi-wall carbon nanotubes. Inhal Toxicol (2010) 1.01
A standardised approach for the dispersion of titanium dioxide nanoparticles in biological media. Nanotoxicology (2012) 0.94
The landscape of somatic copy-number alteration across human cancers. Nature (2010) 31.88
Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell (2004) 9.41
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med (2008) 8.79
Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol (2005) 7.28
Safe handling of nanotechnology. Nature (2006) 7.25
Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect (2003) 6.68
Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods (2005) 6.23
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol (2005) 6.04
Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med (2004) 5.24
Exposure to carbon nanotube material: aerosol release during the handling of unrefined single-walled carbon nanotube material. J Toxicol Environ Health A (2004) 3.96
Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology (2009) 3.52
Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A (2002) 3.49
Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect (2006) 3.16
Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A (2003) 2.82
Evaluating the toxicity of airborne particulate matter and nanoparticles by measuring oxidative stress potential--a workshop report and consensus statement. Inhal Toxicol (2008) 2.53
A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling. Cancer Res (2007) 2.52
Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure. Environ Health Perspect (2006) 2.38
World Trade Center fine particulate matter causes respiratory tract hyperresponsiveness in mice. Environ Health Perspect (2003) 2.36
Health effects of air pollution. J Allergy Clin Immunol (2004) 2.34
Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci U S A (2010) 2.27
Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor. Proc Natl Acad Sci U S A (2005) 2.25
Quinones and aromatic chemical compounds in particulate matter induce mitochondrial dysfunction: implications for ultrafine particle toxicity. Environ Health Perspect (2004) 2.09
Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre Toxicol (2011) 2.08
IAP inhibitors enhance co-stimulation to promote tumor immunity. J Exp Med (2010) 2.07
Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part Fibre Toxicol (2009) 2.06
Ultrafine particle deposition in humans during rest and exercise. Inhal Toxicol (2003) 2.06
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy. Eur Respir J (2012) 2.06
Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre Toxicol (2010) 2.05
Climate change. A global threat to cardiopulmonary health. Am J Respir Crit Care Med (2014) 2.05
Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Aspects Med (2008) 1.92
Processing pathway dependence of amorphous silica nanoparticle toxicity: colloidal vs pyrolytic. J Am Chem Soc (2012) 1.86
Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol (2009) 1.78
Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. J Biol Chem (2006) 1.78
Quantitative techniques for assessing and controlling the dispersion and biological effects of multiwalled carbon nanotubes in mammalian tissue culture cells. ACS Nano (2010) 1.78
Particulate matter exposure impairs systemic microvascular endothelium-dependent dilation. Environ Health Perspect (2004) 1.77
Early childhood lower respiratory illness and air pollution. Environ Health Perspect (2007) 1.77
Use of a stratified oxidative stress model to study the biological effects of ambient concentrated and diesel exhaust particulate matter. Inhal Toxicol (2002) 1.76
Ultrafine particles in the urban air: to the respiratory tract--and beyond? Environ Health Perspect (2002) 1.76
Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano (2011) 1.75
Surface area of particle administered versus mass in determining the pulmonary toxicity of ultrafine and fine carbon black: comparison to ultrafine titanium dioxide. Part Fibre Toxicol (2009) 1.74
Dispersal state of multiwalled carbon nanotubes elicits profibrogenic cellular responses that correlate with fibrogenesis biomarkers and fibrosis in the murine lung. ACS Nano (2011) 1.74
BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition. Proc Natl Acad Sci U S A (2013) 1.72
Acute pulmonary dose-responses to inhaled multi-walled carbon nanotubes. Nanotoxicology (2012) 1.70
Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: the NIEHS Nano GO Consortium. Environ Health Perspect (2013) 1.68
The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials (2008) 1.68
Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes. FASEB J (2006) 1.67
Titanium dioxide nanoparticles: a review of current toxicological data. Part Fibre Toxicol (2013) 1.67
Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. Toxicol Sci (2006) 1.67
Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area. Part Fibre Toxicol (2008) 1.66
Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect (2007) 1.65
Meeting report: hazard assessment for nanoparticles--report from an interdisciplinary workshop. Environ Health Perspect (2007) 1.64
Use of coated silver nanoparticles to understand the relationship of particle dissolution and bioavailability to cell and lung toxicological potential. Small (2013) 1.62
Does Nanoparticle Activity Depend upon Size and Crystal Phase? Nanotoxicology (2008) 1.62
Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical/biological response metrics. J Toxicol Environ Health A (2010) 1.61
Short-term exposure to aged and diluted sidestream cigarette smoke enhances ozone-induced lung injury in B6C3F1 mice. Toxicol Sci (2002) 1.60
Glutamate cysteine ligase modifier subunit deficiency and gender as determinants of acetaminophen-induced hepatotoxicity in mice. Toxicol Sci (2007) 1.60
Development of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing mice. Am J Respir Crit Care Med (2007) 1.60
The outdoor air pollution and brain health workshop. Neurotoxicology (2012) 1.60
The adjuvant effect of ambient particulate matter is closely reflected by the particulate oxidant potential. Environ Health Perspect (2009) 1.57
MetaMapp: mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarity. BMC Bioinformatics (2012) 1.56
Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signaling. Toxicol Sci (2009) 1.55
Respiratory toxicologic pathology of inhaled diacetyl in sprague-dawley rats. Toxicol Pathol (2008) 1.54
Activation of the mouse heme oxygenase-1 gene by 15-deoxy-Delta(12,14)-prostaglandin J(2) is mediated by the stress response elements and transcription factor Nrf2. Antioxid Redox Signal (2002) 1.53
Acute cobalt-induced lung injury and the role of hypoxia-inducible factor 1alpha in modulating inflammation. Toxicol Sci (2010) 1.53
Time course for inhibition of lipopolysaccharide-induced lung injury by genistein: relationship to alteration in nuclear factor-kappaB activity and inflammatory agents. Crit Care Med (2003) 1.52
Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-Mediated hepatotoxicity. Toxicol Sci (2005) 1.51
The U.S. Environmental Protection Agency Particulate Matter Health Effects Research Centers Program: a midcourse report of status, progress, and plans. Environ Health Perspect (2003) 1.51
Cerium oxide nanoparticle-induced pulmonary inflammation and alveolar macrophage functional change in rats. Nanotoxicology (2010) 1.50
Confirmation of gene expression-based prediction of survival in non-small cell lung cancer. Clin Cancer Res (2008) 1.49
Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. ACS Nano (2010) 1.49
Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction. Part Fibre Toxicol (2008) 1.49
C₆₀ exposure augments cardiac ischemia/reperfusion injury and coronary artery contraction in Sprague Dawley rats. Toxicol Sci (2014) 1.47
Air-pollutant chemicals and oxidized lipids exhibit genome-wide synergistic effects on endothelial cells. Genome Biol (2007) 1.46
Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation (2002) 1.46
Fluorescence-based microtiter plate assay for glutamate-cysteine ligase activity. Anal Biochem (2003) 1.46
Pulmonary function, diffusing capacity, and inflammation in healthy and asthmatic subjects exposed to ultrafine particles. Inhal Toxicol (2004) 1.45
Direct fibrogenic effects of dispersed single-walled carbon nanotubes on human lung fibroblasts. J Toxicol Environ Health A (2010) 1.45
Airway inflammation is associated with mucous cell metaplasia and increased intraepithelial stored mucosubstances in horses. Vet J (2005) 1.44
Sharpening the focus on occupational safety and health in nanotechnology. Scand J Work Environ Health (2008) 1.44
Inhalation of ultrafine particles alters blood leukocyte expression of adhesion molecules in humans. Environ Health Perspect (2006) 1.44
An in vivo and in vitro toxicological characterisation of realistic nanoscale CeO₂ inhalation exposures. Nanotoxicology (2012) 1.43
Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part Fibre Toxicol (2009) 1.41
Ultrafine particle deposition in subjects with asthma. Environ Health Perspect (2004) 1.40
Raw single-wall carbon nanotubes induce oxidative stress and activate MAPKs, AP-1, NF-kappaB, and Akt in normal and malignant human mesothelial cells. Environ Health Perspect (2008) 1.40
The health effects of non-industrial indoor air pollution. J Allergy Clin Immunol (2007) 1.40
Health effects of inhaled engineered and incidental nanoparticles. Crit Rev Toxicol (2009) 1.39
Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem (2005) 1.39
Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part Fibre Toxicol (2010) 1.38